Translational Development Acquisition Corp (TDAC) Fair Value & Analysis
Financial Services · US · Market cap $208M
Fair value as of: Jun 26, 2026
Analysis
Translational Development Acquisition Corp (TDAC) currently trades at $10.72, while our model-based Fair Value estimate is $4.28 — implying the stock looks roughly 60.1% overvalued today. We read business quality at 87/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Translational Development Acquisition Corp (TDAC) undervalued?
What is the fair value of TDAC?
What is the quality score of TDAC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.